Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives

Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system characterized by relapses and autoimmunity caused by antibodies against the astrocyte water channel protein aquaporin-4. Over the past decade, there have been significant advances in the biologic...

Full description

Bibliographic Details
Main Authors:	Tzu-Lun Huang, Jia-Kang Wang, Pei-Yao Chang, Yung-Ray Hsu, Cheng-Hung Lin, Kung-Hung Lin, Rong-Kung Tsai
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	International Journal of Molecular Sciences
Subjects:	neuromyelitis optica spectrum disease aquaporin-4 myelin oligodendrocyte glycoprotein ocular coherence tomography complement microcystic macular degeneration
Online Access:	https://www.mdpi.com/1422-0067/23/14/7908

Similar Items

Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder
by: Vahid Shaygannejad, et al.
Published: (2021-01-01)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
by: Mader Simone, et al.
Published: (2011-12-01)

Autoantibodies in patients with neuromyelitis optica
by: Xin FAN, et al.
Published: (2016-10-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies
by: Patrick Murtagh, et al.
Published: (2022-07-01)

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
by: Marco A. Lana-Peixoto, et al.
Published: (2019-06-01)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
by: Kerri Prain, et al.
Published: (2019-10-01)

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
by: Jae-Won Hyun, et al.
Published: (2022-04-01)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Hai Chen, et al.
Published: (2016-01-01)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Burak Arslan, et al.
Published: (2021-08-01)

Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
by: Michela Ada Noris Ferilli, et al.
Published: (2021-12-01)

The developmental history of study on neuromyelitis optica
by: Kai FENG, et al.
Published: (2014-09-01)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
by: Livia Sophie Hofer, et al.
Published: (2020-06-01)

Symptomatic narcolepsy as a presenting feature of neuromyelitis optica
by: Pradeep Kallollimath, et al.
Published: (2018-01-01)

Detection and clinical value of NMO-IgG in neuromyelitis optica
by: De-hui HUANG, et al.
Published: (2014-09-01)

Neuromyelitis optica - an update: 2007-2009
by: Jacob Anu
Published: (2009-01-01)

Visual function and disability are associated with microcystic macular edema, macular and peripapillary vessel density in patients with neuromyelitis optica spectrum disorder
by: Jin Li, et al.
Published: (2022-11-01)

Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
by: Oliver Schmetzer, et al.
Published: (2021-03-01)

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study
by: Yanlin Lang, et al.
Published: (2023-01-01)

Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01)

Relapses and Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab: A Swedish Single-Center Study
by: Olof Carlsson, et al.
Published: (2024-01-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

Differential diagnosis of demyelinating diseases: what's new?
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-08-01)

Efficacy and safety of rituximab in central nervous system demyelinating disorders
by: Varsha A Patil, et al.
Published: (2021-01-01)

Clinical characteristics of late ⁃ onset and very late ⁃ onset neuromyelitis optica spectrum disorders
by: ZHANG Jing, et al.
Published: (2022-09-01)

Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
by: Eun Bin Cho, et al.
Published: (2024-03-01)

The Emerging Role of Microglia in Neuromyelitis Optica
by: Tingjun Chen, et al.
Published: (2021-02-01)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
by: Narayanan Unni, et al.
Published: (2013-01-01)

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01)

Therapeutic efficacy of plasma exchange in neuromyelitis optica
by: Rajesh Kumar, et al.
Published: (2018-01-01)

MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?
by: Dominika Czarnecka, et al.
Published: (2019-10-01)

Diagnostic modalities in multiple sclerosis: Perspectives in children
by: I-Jun Chou, et al.
Published: (2014-04-01)

Association Between Helicobacter Pylori Infection and Seronegative Neuromyelitis Optica Spectrum Disorder
by: Mahdi Barzegar, et al.
Published: (2023-01-01)

Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica
by: Girish Baburao Kulkarni, et al.
Published: (2014-01-01)

Research progress of neuromyelitis optica spectrum disorders: Chinese scholars' reports published abroad
by: Jie-xi WEN, et al.
Published: (2016-09-01)

A Rare Case Report: MOGAD with Optic Neuritis- without Spinal İnvolvement
by: Canan Akünal Türel, et al.
Published: (2023-04-01)

Neuromyelitis optica spectrum disorder: a pediatric case report
by: Mujgan Arslan, et al.
Published: (2017-09-01)

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
by: Edgar Carnero Contentti, et al.
Published: (2021-09-01)

Clinical and brain MRI appearances in neuromyelitis optica
by: Shijuan ZHANG, et al.
Published: (2011-06-01)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
by: Pınar Özçelik, et al.
Published: (2017-06-01)